Related Experiment Video

Updated: Aug 14, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup

M G Valsecchi1, G Masera

  • 1Istituto di Statistica Medica e Biometria, Università di Milano, Italy.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|December 1, 1996
PubMed

Insights

International collaboration is crucial for advancing childhood acute lymphoblastic leukemia (ALL) research. A prospective meta-analysis strategy offers a feasible and rigorous approach to evaluating new treatments for ALL patients.

Area of Science:

  • Pediatric Oncology
  • Clinical Research Methodology
  • Hematology

Background:

  • Therapeutic advancements in childhood acute lymphoblastic leukemia (ALL) necessitate novel trial designs for outcome assessment.
  • Genetic and molecular discoveries identify rare ALL subgroups requiring specialized treatment evaluations.
  • Existing clinical trial sizes pose challenges for detecting incremental improvements in common ALL cases.

Purpose of the Study:

  • To address challenges in evaluating new treatments for childhood acute lymphoblastic leukemia (ALL).
  • To propose a feasible and scientifically rigorous international research strategy for ALL.
  • To stimulate discussion on prospective meta-analysis for pediatric oncology clinical trials.

Main Methods:

  • Discusses the limitations of retrospective meta-analysis and traditional randomized controlled trials in ALL research.
  • Proposes a prospective meta-analysis strategy for international intergroup cooperation in ALL studies.
  • Highlights decentralized study management allowing individual group protocol adherence while pooling data.

Main Results:

  • Prospective meta-analysis enables international cooperation by standardizing key research questions across diverse protocols.
  • Decentralized management enhances feasibility while maintaining scientific rigor in multi-center ALL studies.
  • This approach facilitates the evaluation of treatments for both common and rare subgroups of childhood ALL.

Conclusions:

  • Prospective meta-analysis is a viable strategy to overcome limitations in current ALL clinical research.
  • International collaboration through prospective meta-analysis can accelerate therapeutic progress in pediatric oncology.
  • Further debate on the methodological and practical aspects of this research strategy is encouraged.

More Related Videos

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...